← FDA DRUG APPROVALS

FDA ANDA · ANDA202349

ESTRADIOL VALERATE AND DIENOGEST

Sponsor: WATSON LABS INC

APPLICATION
ANDA202349
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ESTRADIOL VALERATE AND DIENOGESTPrescription
DIENOGEST N/A,2MG,3MG,N/A,N/A, ESTRADIOL VALERATE 3MG,2MG,2MG,1MG,N/A · TABLET · ORAL

Approval history

2017-05-09OriginalTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →